Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach

This work was supported by Grants SAF2015-71304-REDT, SAF2016-76520-R, SAF2013-4874R, SAF2015-65267-R, and BIO2014-57518 of the Spanish Ministry of Economy and Competiveness; PII4/00372 from the Health Institute Carlos III; PROMETEOII/2014/071 of Generalitat Valenciana; P_37_732/2016 REDBRAIN of the European Regional Development Fund; Competitiveness Operational Program 2014-2020; and the ERC Advanced Grant RadMed 294683 and COST action 15120 OpenMultiMed (H.H.H.W.S.). M.P. is the recipient of a FPU fellowship of Autonomous University of Madrid. E.G. is supported by a European-cofunded Beatriu de Pinos fellowship. R.L. is supproted by the Miguel Servet II fellow (CPII16/00014)Cuadrado, A.; Manda, G.; Hassan, A.; Alcaraz Tormo, MJ.; Barbas, C.; Daiber, A.; Ghezzi, P.... (2018). Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach. Pharmacological Reviews. 70(2):348-383. https://doi.org/10.1124/pr.117.014753348383702Abdanipour, A., Tiraihi, T., Noori-Zadeh, A., Majdi, A., & Gosaili, R. (2014). Evaluation of Lovastatin Effects on Expression of Anti-apoptotic Nrf2 and PGC-1α Genes in Neural Stem Cells Treated with Hydrogen Peroxide. Molecular Neurobiology, 49(3), 1364-1372. doi:10.1007/s12035-013-8613-5Abed, D. A., Goldstein, M., Albanyan, H., Jin, H., & Hu, L. (2015). Discovery of direct inhibitors of Keap1–Nrf2 protein–protein interaction as potential therapeutic and preventive agents. Acta Pharmaceutica Sinica B, 5(4), 285-299. doi:10.1016/j.apsb.2015.05.008Aleksunes, L. M. (2006). Up-regulation of NAD(P)H quinone oxidoreductase 1 during human liver injury. World Journal of Gastroenterology, 12(12), 1937. doi:10.3748/wjg.v12.i12.1937Aleksunes, L. M., & Manautou, J. E. (2007). Emerging Role of Nrf2 in Protecting Against Hepatic and Gastrointestinal Disease. Toxicologic Pathology, 35(4), 459-473. doi:10.1080/01926230701311344Al-Huseini, L. M. A., Aw Yeang, H. X., Sethu, S., Alhumeed, N., Hamdam, J. M., Tingle, Y., … Sathish, J. G. (2013). Nuclear Factor-erythroid 2 (NF-E2) p45-related Factor-2 (Nrf2) Modulates Dendritic Cell Immune Function through Regulation of p38 MAPK-cAMP-responsive Element Binding Protein/Activating Transcription Factor 1 Signaling. Journal of Biological Chemistry, 288(31), 22281-22288. doi:10.1074/jbc.m113.483420Al-Jaderi, Z., & Maghazachi, A. (2015). Vitamin D3 and Monomethyl Fumarate Enhance Natural Killer Cell Lysis of Dendritic Cells and Ameliorate the Clinical Score in Mice Suffering from Experimental Autoimmune Encephalomyelitis. Toxins, 7(11), 4730-4744. doi:10.3390/toxins7114730Altmeyer, P. J., Mattlies, U., Pawlak, F., Hoffmann, K., Frosch, P. J., Ruppert, P., … Joshi, R. K. (1994). Antipsoriatic effect of fumaric acid derivatives. Journal of the American Academy of Dermatology, 30(6), 977-981. doi:10.1016/s0190-9622(94)70121-0Archer, E., Pavela, G., & Lavie, C. J. (2015). The Inadmissibility of What We Eat in America and NHANES Dietary Data in Nutrition and Obesity Research and the Scientific Formulation of National Dietary Guidelines. Mayo Clinic Proceedings, 90(7), 911-926. doi:10.1016/j.mayocp.2015.04.009Arlt, A., Sebens, S., Krebs, S., Geismann, C., Grossmann, M., Kruse, M.-L., … Schäfer, H. (2012). Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity. Oncogene, 32(40), 4825-4835. doi:10.1038/onc.2012.493Artaud-Macari, E., Goven, D., Brayer, S., Hamimi, A., Besnard, V., Marchal-Somme, J., … Bonay, M. (2013). Nuclear Factor Erythroid 2-Related Factor 2 Nuclear Translocation Induces Myofibroblastic Dedifferentiation in Idiopathic Pulmonary Fibrosis. Antioxidants & Redox Signaling, 18(1), 66-79. doi:10.1089/ars.2011.4240Ashabi, G., Khalaj, L., Khodagholi, F., Goudarzvand, M., & Sarkaki, A. (2014). Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia. Metabolic Brain Disease, 30(3), 747-754. doi:10.1007/s11011-014-9632-2Attucks, O. C., Jasmer, K. J., Hannink, M., Kassis, J., Zhong, Z., Gupta, S., … Kostura, M. J. (2014). Induction of Heme Oxygenase I (HMOX1) by HPP-4382: A Novel Modulator of Bach1 Activity. PLoS ONE, 9(7), e101044. doi:10.1371/journal.pone.0101044Aviello, G., & Knaus, U. (2016). ROS in gastrointestinal inflammation: Rescue Or Sabotage? British Journal of Pharmacology, 174(12), 1704-1718. doi:10.1111/bph.13428Bonsignori, M., Kreider, E. F., Fera, D., Meyerhoff, R. R., Bradley, T., Wiehe, K., … Haynes, B. F. (2017). Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies. Science Translational Medicine, 9(381), eaai7514. doi:10.1126/scitranslmed.aai7514Bahadoran, Z., Mirmiran, P., Hosseinpanah, F., Rajab, A., Asghari, G., & Azizi, F. (2012). Broccoli sprouts powder could improve serum triglyceride and oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial. Diabetes Research and Clinical Practice, 96(3), 348-354. doi:10.1016/j.diabres.2012.01.009Baillie, J. K., Arner, E., Daub, C., De Hoon, M., Itoh, M., … Kawaji, H. (2017). Analysis of the human monocyte-derived macrophage transcriptome and response to lipopolysaccharide provides new insights into genetic aetiology of inflammatory bowel disease. PLOS Genetics, 13(3), e1006641. doi:10.1371/journal.pgen.1006641Baird, L., & Dinkova-Kostova, A. T. (2013). Diffusion dynamics of the Keap1–Cullin3 interaction in single live cells. Biochemical and Biophysical Research Communications, 433(1), 58-65. doi:10.1016/j.bbrc.2013.02.065Banning, A., & Brigelius-Flohé, R. (2005). NF-κB, Nrf2, and HO-1 Interplay in Redox-Regulated VCAM-1 Expression. Antioxidants & Redox Signaling, 7(7-8), 889-899. doi:10.1089/ars.2005.7.889Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2010). Network medicine: a network-based approach to human disease. Nature Reviews Genetics, 12(1), 56-68. doi:10.1038/nrg2918Batthyany CI Lopez GV (2015) Nitroalkene Tocopherols and Analogs Thereof for Use in the Treatment and Prevention of Inflammation Related Conditions, Complexa, Radnor, PA.Bauer, P. V., & Duca, F. A. (2016). Targeting the gastrointestinal tract to treat type 2 diabetes. Journal of Endocrinology, 230(3), R95-R113. doi:10.1530/joe-16-0056Bergström, P., von Otter, M., Nilsson, S., Nilsson, A.-C., Nilsson, M., Andersen, P. M., … Zetterberg, H. (2013). Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 15(1-2), 130-137. doi:10.3109/21678421.2013.839708Bertrand, H. C., Schaap, M., Baird, L., Georgakopoulos, N. D., Fowkes, A., Thiollier, C., … Wells, G. (2015). Design, Synthesis, and Evaluation of Triazole Derivatives That Induce Nrf2 Dependent Gene Products and Inhibit the Keap1–Nrf2 Protein–Protein Interaction. Journal of Medicinal Chemistry, 58(18), 7186-7194. doi:10.1021/acs.jmedchem.5b00602Beurel, E., Grieco, S. F., & Jope, R. S. (2015). Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases. Pharmacology & Therapeutics, 148, 114-131. doi:10.1016/j.pharmthera.2014.11.016Bhatt, J. K., Thomas, S., & Nanjan, M. J. (2012). Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutrition Research, 32(7), 537-541. doi:10.1016/j.nutres.2012.06.003Blewett, M. M., Xie, J., Zaro, B. W., Backus, K. M., Altman, A., Teijaro, J. R., & Cravatt, B. F. (2016). Chemical proteomic map of dimethyl fumarate–sensitive cysteines in primary human T cells. Science Signaling, 9(445), rs10-rs10. doi:10.1126/scisignal.aaf7694Bolaños, J. P. (2016). Bioenergetics and redox adaptations of astrocytes to neuronal activity. Journal of Neurochemistry, 139(S2), 115-125. doi:10.1111/jnc.13486Bourdonnay, E., Morzadec, C., Fardel, O., & Vernhet, L. (2009). Redox-sensitive regulation of gene expression in human primary macrophages exposed to inorganic arsenic. Journal of Cellular Biochemistry, 107(3), 537-547. doi:10.1002/jcb.22155Bowie, A., & O’Neill, L. A. . (2000). Oxidative stress and nuclear factor-κB activation. Biochemical Pharmacology, 59(1), 13-23. doi:10.1016/s0006-2952(99)00296-8Brasnyó, P., Molnár, G. A., Mohás, M., Markó, L., Laczy, B., Cseh, J., … Wittmann, I. (2011). Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. British Journal of Nutrition, 106(3), 383-389. doi:10.1017/s0007114511000316Brennan, M. S., Matos, M. F., Richter, K. E., Li, B., & Scannevin, R. H. (2017). The NRF2 transcriptional target, OSGIN1, contributes to monomethyl fumarate-mediated cytoprotection in human astrocytes. Scientific Reports, 7(1). doi:10.1038/srep42054Brüne, B., Dehne, N., Grossmann, N., Jung, M., Namgaladze, D., Schmid, T., … Weigert, A. (2013). Redox Control of Inflammation in Macrophages. Antioxidants & Redox Signaling, 19(6), 595-637. doi:10.1089/ars.2012.4785Buendia, I., Gómez-Rangel, V., González-Lafuente, L., Parada, E., León, R., Gameiro, I., … López, M. G. (2015). Neuroprotective mechanism of the novel melatonin derivative Neu-P11 in brain ischemia related models. Neuropharmacology, 99, 187-195. doi:10.1016/j.neuropharm.2015.07.014Buendia, I., Michalska, P., Navarro, E., Gameiro, I., Egea, J., & León, R. (2016). Nrf2–ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. Pharmacology & Therapeutics, 157, 84-104. doi:10.1016/j.pharmthera.2015.11.003Buendia, I., Navarro, E., Michalska, P., Gameiro, I., Egea, J., Abril, S., … León, R. (2015). New melatonin–cinnamate hybrids as multi-target drugs for neurodegenerative diseases: Nrf2-induction, antioxidant effect and neuroprotection. Future Medicinal Chemistry, 7(15), 1961-1969. doi:10.4155/fmc.15.99Cajaraville, M. P., Bebianno, M. J., Blasco, J., Porte, C., Sarasquete, C., & Viarengo, A. (2000). The use of biomarkers to assess the impact of pollution in coastal environments of the Iberian Peninsula: a practical approach. Science of The Total Environment, 247(2-3), 295-311. doi:10.1016/s0048-9697(99)00499-4Cazanave, S. C., Wang, X., Zhou, H., Rahmani, M., Grant, S., Durrant, D. E., … Sanyal, A. J. (2014). Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosis. Cell Death & Differentiation, 21(8), 1303-1312. doi:10.1038/cdd.2014.49Cescon, D. W., She, D., Sakashita, S., Zhu, C.-Q., Pintilie, M., Shepherd, F. A., & Tsao, M.-S. (2015). NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma. Clinical Cancer Research, 21(11), 2499-2505. doi:10.1158/1078-0432.ccr-14-2206Chen, H., Assmann, J. C., Krenz, A., Rahman, M., Grimm, M., Karsten, C. M., … Schwaninger, M. (2014). Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate’s protective effect in EAE. Journal of Clinical Investigation, 124(5), 2188-2192. doi:10.1172/jci72151Chen, J., Yu, Y., Ji, T., Ma, R., Chen, M., Li, G., … Cai, X. (2016). Clinical implication of Keap1 and phosphorylated Nrf2 expression in hepatocellular carcinoma. Cancer Medicine, 5(10), 2678-2687. doi:10.1002/cam4.788Chen, W., Sun, Z., Wang, X.-J., Jiang, T., Huang, Z., Fang, D., & Zhang, D. D. (2009). Direct Interaction between Nrf2 and p21Cip1/WAF1 Upregulates the Nrf2-Mediated Antioxidant Response. Molecular Cell, 34(6), 663-673. doi:10.1016/j.molcel.2009.04.029Chen, Y., Inoyama, D., Kong, A.-N. T., Beamer, L. J., & Hu, L. (2011). Kinetic Analyses of Keap1-Nrf2 Interaction and Determination of the Minimal Nrf2 Peptide Sequence Required for Keap1 Binding Using Surface Plasmon Resonance. Chemical Biology & Drug Design, 78(6), 1014-1021. doi:10.1111/j.1747-0285.2011.01240.xChen, Y.-C., Wu, Y.-R., Wu, Y.-C., Lee-Chen, G.-J., & Chen, C.-M. (2013). Genetic analysis of NFE2L2 promoter variation in Taiwanese Parkinson’s disease. Parkinsonism & Related Disorders, 19(2), 247-250. doi:10.1016/j.parkreldis.2012.10.018Chin, M. P., Reisman, S. A., Bakris, G. L., O’Grady, M., Linde, P. G., McCullough, P. A., … Meyer, C. J. (2014). Mechanisms Contributing to Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl. American Journal of Nephrology, 39(6), 499-508. doi:10.1159/000362906Chiu, C.-T., Wang, Z., Hunsberger, J. G., & Chuang, D.-M. (2013). Therapeutic Potential of Mood Stabilizers Lithium and Valproic Acid: Beyond Bipolar Disorder. Pharmacological Reviews, 65(1), 105-142. doi:10.1124/pr.111.005512Cho, H.-Y., & Kleeberger, S. R. (2010). Nrf2 protects against airway disorders. Toxicology and Applied Pharmacology, 244(1), 43-56. doi:10.1016/j.taap.2009.07.024Cho, H.-Y., Marzec, J., & Kleeberger, S. R. (2015). Functional polymorphisms in Nrf2: implications for human disease. Free Radical Biology and Medicine, 88, 362-372. doi:10.1016/j.freeradbiomed.2015.06.012Cho, H.-Y., Reddy, S. P. M., Yamamoto, M., & Kleeberger, S. R. (2004). The transcription factor NRF2 protects against pulmonary fibrosis. The FASEB Journal, 18(11), 1258-1260. doi:10.1096/fj.03-1127fjeCho, Y.-E., Moon, P.-G., Lee, J.-E., Singh, T. S. K., Kang, W., Lee, H.-C., … Baek, M.-C. (2013). Integrative analysis of proteomic and transcriptomic data for identification of pathways related to simvastatin-induced hepatotoxicity. PROTEOMICS, 13(8), 1257-1275. doi:10.1002/pmic.201200368Chowdhry, S., Zhang, Y., McMahon, M., Sutherland, C., Cuadrado, A., & Hayes, J. D. (2012). Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. Oncogene, 32(32), 3765-3781. doi:10.1038/onc.2012.388Christou, H., Morita, T., Hsieh, C.-M., Koike, H., Arkonac, B., Perrella, M. A., & Kourembanas, S. (2000). Prevention of Hypoxia-Induced Pulmonary Hypertension by Enhancement of Endogenous Heme Oxygenase-1 in the Rat. Circulation Research, 86(12), 1224-1229. doi:10.1161/01.res.86.12.1224Chuengsamarn, S., Rattanamongkolgul, S., Phonrat, B., Tungtrongchitr, R., & Jirawatnotai, S. (2014). Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. The Journal of Nutritional Biochemistry, 25(2), 144-150. doi:10.1016/j.jnutbio.2013.09.013Ci, X., Zhou, J., Lv, H., Yu, Q., Peng, L., & Hua, S. (2017). Betulin exhibits anti-inflammatory activity in LPS-stimulated macrophages and endotoxin-shocked mice through an AMPK/AKT/Nrf2-dependent mechanism. Cell Death & Disease, 8(5), e2798-e2798. doi:10.1038/cddis.2017.39Cleasby, A., Yon, J., Day, P. J., Richardson, C., Tickle, I. J., Williams, P. A., … Davies, T. G. (2014). Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO. PLoS ONE, 9(6), e98896. doi:10.1371/journal.pone.0098896Comandini, A., Marzano, V., Curradi, G., Federici, G., Urbani, A., & Saltini, C. (2010). Markers of anti-oxidant response in tobacco smoke exposed subjects: A data-mining review. Pulmonary Pharmacology & Therapeutics, 23(6), 482-492. doi:10.1016/j.pupt.2010.05.006Córdova, E., Velázquez-Cruz, R., Centeno, F., Baca, V., & Orozco, L. (2010). The NRF2 gene variant, -653G/A, is associated with nephritis in childhood-onset systemic lupus erythematosus. Lupus, 19(10), 1237-1242. doi:10.1177/0961203310367917Croze, E., Yamaguchi, K. D., Knappertz, V., Reder, A. T., & Salamon, H. (2012). Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis. The Pharmacogenomics Journal, 13(5), 443-451. doi:10.1038/tpj.2012.27Cuadrado, A. (2015). Structural and functional characterization of Nrf2 degradation by glycogen synthase kinase 3/β-TrCP. Free Radical Biology and Medicine, 88, 147-157. doi:10.1016/j.freeradbiomed.2015.04.029Cuadrado, A., Martín-Moldes, Z., Ye, J., & Lastres-Becker, I. (2014). Transcription Factors NRF2 and NF-κB Are Coordinated Effectors of the Rho Family, GTP-binding Protein RAC1 during Inflammation. Journal of Biological Chemistry, 289(22), 15244-15258. doi:10.1074/jbc.m113.540633Cuadrado, A., Moreno-Murciano, P., & Pedraza-Chaverri, J. (2009). The transcription factor Nrf2 as a new therapeutic target in Parkinson’s disease. Expert Opinion on Therapeutic Targets, 13(3), 319-329. doi:10.1517/13543780802716501Cui, Y., Wang, Q., Li, X., & Zhang, X. (2013). Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation. Redox Biology, 1(1), 433-440. doi:10.1016/j.redox.2013.08.003Datta, S., Kundu, S., Ghosh, P., De, S., Ghosh, A., & Chatterjee, M. (2014). Correlation of oxidant status with oxidative tissue damage in patients with rheumatoid arthritis. Clinical Rheumatology, 33(11), 1557-1564. doi:10.1007/s10067-014-2597-zDe la Vega, M. R., Dodson, M., Gross, C., Mansour, H. M., Lantz, R. C., Chapman, E., … Zhang, D. D. (2016). Role of Nrf2 and Autophagy in Acute Lung Injury. Current Pharmacology Reports, 2(2), 91-101. doi:10.1007/s40495-016-0053-2DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., … Tuveson, D. A. (2011). Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature, 475(7354), 106-109. doi:10.1038/nature10189De Zeeuw, D., Akizawa, T., Audhya, P., Bakris, G. L., Chin, M., Christ-Schmidt, H., … Chertow, G. M. (2013). Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease. New England Journal of Medicine, 369(26), 2492-2503. doi:10.1056/nejmoa1306033Diotallevi, M., Checconi, P., Palamara, A. T., Celestino, I., Coppo, L., Holmgren, A., … Ghezzi, P. (2017). Glutathione Fine-Tunes the Innate Immune Response toward Antiviral Pathways in a Macrophage Cell Line Independently of Its Antioxidant Properties. Frontiers in Immunology, 8. doi:10.3389/fimmu.2017.01239Duran, C. G., Burbank, A. J., Mills, K. H., Duckworth, H. R., Aleman, M. M., Kesic, M. J., … Hernandez, M. L. (2016). A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation. Respiratory Research, 17(1). doi:10.1186/s12931-016-0406-8Eades, G., Yang, M., Yao, Y., Zhang, Y., & Zhou, Q. (2011). miR-200a Regulates Nrf2 Activation by TargetingKeap1mRNA in Breast Cancer Cells. Journal of Biological Chemistry, 286(47), 40725-40733. doi:10.1074/jbc.m111.275495Egea, J., Buendia, I., Parada, E., Navarro, E., Rada, P., Cuadrado, A., … León, R. (2015). Melatonin-sulforaphane hybrid ITH12674 induces neuroprotection in oxidative stress conditions by a ‘drug-prodrug’ mechanism of action. British Journal of Pharmacology, 172(7), 1807-1821. doi:10.1111/bph.13025Ellrichmann, G., Petrasch-Parwez, E., Lee, D.-H., Reick, C., Arning, L., Saft, C., … Linker, R. A. (2011). Efficacy of Fumaric Acid Esters in the R6/2 and YAC128 Models of Huntington’s Disease. PLoS ONE, 6(1), e16172. doi:10.1371/journal.pone.0016172El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000). Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I. Journal of Biological Chemistry, 275(1), 223-228. doi:10.1074/jbc.275.1.223Eminel, S., Jin, N., Rostami, M., Dibbert, S., Mrowietz, U., & Suhrkamp, I. (2016). Dimethyl- and monomethylfumarate regulate indoleamine 2,3-dioxygenase (IDO) activity in human immune cells. Experimental Dermatology, 26(8), 685-690. doi:10.1111/exd.13138Emmink, B. L., Verheem, A., Van Houdt, W. J., Steller, E. J. A., Govaert, K. M., Pham, T. V., … Kranenburg, O. (2013). The secretome of colon cancer stem cells contains drug-metabolizing enzymes. Journal of Proteomics, 91, 84-96. doi:10.1016/j.jprot.2013.06.027Evans, M. D., Cooke, M. S., Akil, M., Samanta, A., & Lunec, J. (2000). Aberrant Processing of Oxidative DNA Damage in Systemic Lupus Erythematosus. Biochemical and Biophysical Research Communications, 273(3), 894-898. doi:10.1006/bbrc.2000.3078Fagone, P., Patti, F., Mangano, K., Mammana, S., Coco, M., Touil-Boukoffa, C., … Nicoletti, F. (2013). Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis. Journal of Neuroimmunology, 261(1-2), 82-86. doi:10.1016/j.jneuroim.2013.04.013Finkelstein, R., Fraser, R. S., Ghezzo, H., & Cosio, M. G. (1995). Alveolar inflammation and its relation to emphysema in smokers. American Journal of Respiratory and Critical Care Medicine, 152(5), 1666-1672. doi:10.1164/ajrccm.152.5.7582312Fox, R. J., Miller, D. H., Phillips, J. T., Hutchinson, M., Havrdova, E., Kita, M., … Dawson, K. T. (2012). Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis. New England Journal of Medicine, 367(12), 1087-1097. doi:10.1056/nejmoa1206328Freitas, A. E., Egea, J., Buendia, I., Gómez-Rangel, V., Parada, E., Navarro, E., … Lopez, M. G. (2015). Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in Mice. Molecular Neurobiology, 53(5), 3030-3045. doi:10.1007/s12035-015-9182-6Frijhoff, J., Winyard, P. G., Zarkovic, N., Davies, S. S., Stocker, R., Cheng, D., … Ghezzi, P. (2015). Clinical Relevance of Biomarkers of Oxidative Stress. Antioxidants & Redox Signaling, 23(14), 1144-1170. doi:10.1089/ars.2015.6317Frostegård, J., Svenungsson, E., Wu, R., Gunnarsson, I., Lundberg, I. E., Klareskog, L., … Witztum, J. L. (2005). Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis & Rheumatism, 52(1), 192-200. doi:10.1002/art.20780Gao, J., Chang, M. T., Johnsen, H. C., Gao, S. P., Sylvester, B. E., Sumer, S. O., … Sander, C. (2017). 3D clusters of somatic mutati